Passage Bio, Inc. (PASG) Reports In-Line Q1 EPS

Passage Bio, Inc. (NASDAQ: PASG) reported Q1 EPS of ($0.25), in-line with the analyst estimate of ($0.25).

For earnings history and earnings-related data on Passage Bio, Inc. (PASG) click here.

You May Also Be Interested In

• 'Ocean of opportunity': Wolfe initiates SpaceX at Buy ahead of historic IPO
• 22nd Century Group files prospectus for warrant share resale
• 51Talk Online Education Group (COE) Reports Q1 EPS of $0.00